Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-20

Clinical Trial Update: Randomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD - Israel [Phase 2]

View source ↗

Summary

Phase 2 randomized, placebo-controlled study of MDMA-assisted therapy for PTSD in Israel was terminated; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Lykos Therapeutics | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: TERMINATED | Results posted: 2021-09-20